Eylea, 2 mg/0,05 ml, injection solution in Durchstechflasche

( ARTG ) EYLEA (aflibercept) is indicated in adults for the treatment of: - neovascular (wet) age-related macular degeneration (wet AMD) - visual impairment due to macular oedema secondary to central retinal vein occlusion (CRVO) - diabetic macular oedema (DME) - visual impairment due to macular oedema secondary to branch retinal vein occlusion (BRVO) - visual impairment due to myopic choroidal neovascularisation (myopic CNV)